Skip to main content
. Author manuscript; available in PMC: 2023 Oct 1.
Published in final edited form as: J Stroke Cerebrovasc Dis. 2022 Aug 30;31(10):106724. doi: 10.1016/j.jstrokecerebrovasdis.2022.106724

Table 1:

Summary of baseline characteristics (mean ± 95% CI) of participants for each subject group

Baseline Characteristics Drug
(n=44)		 Placebo
(n=45)
Age (yrs) 59.6 ± 3.2 57.5 ± 3.0
Time post-stroke (yrs) 5.7 ± 1.4 7.2 ± 2.2
Fugl-Meyer Upper Extremity 15.4 ± 2.3 14.6 ± 1.7
Gender (Female/Male) 16 / 28 18 / 27
Paretic hand (Right/Left) 19 / 25 18 / 27
CMSA-H Score (2/3) 12 / 32 18 / 27